The impact of coronavirus disease 2019 (COVID-19) pandemic on urologic cancer care: did we throw the baby out with the bathwater?
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
It has been more than two years since World Health Organization (WHO) declared the pandemic of coronavirus disease 2019 (COVID-19), with more than 6 million fatal cases of the disease having been reported worldwide and the true death toll being estimated to be much higher (1).Both the need for rearranging wards in order to provide care to critically ill patients, as well as social distancing and lockdown policies, seen especially at the early stage of the pandemic, led to a marked decrease in healthcare services provided to non-covid patients (2), including individuals suspected of or harboring a malignant disease (3). High levels of pandemic-related anxiety have been recorded in many populations and cancer patients had been reported to be more worried about the coronavirus than about their malignant disease (4). Recently, Grant et al. demonstrated a large-scale primary care avoidance in patients with cancer- related symptoms, that did not increase until the end of the first COVID-19 year (5). In a modelling study by Maringe et al. significant numbers of additional deaths for breast, colorectal, lung, and esophageal cancer (...)
Translational Andrology and Urology , éditorial en libre accès, 2022